we are dedicated to our mission of striving to extend survival in some of the most aggressive forms of cancer.
We joined Novocure for the opportunity to make a difference in cancer. Establishing, building and growing an innovative company to provide patients with a new cancer treatment modality demands drive, commitment and an unwavering focus on the scientific evidence to keep moving forward regardless of the obstacles or resistance that may be encountered. We are passionate about advancing our business and further developing our science to bring our therapy to all patients who may benefit around the world.
Bill Doyle
Executive Chairman
Asaf Danziger
Chief Executive Officer
Ashley Cordova, Chief Financial Officer
corporate officers and executive leadership
William F. Doyle
Executive Chairman
Asaf Danziger
Chief Executive Officer
Yoram Palti, M.D., Ph.D.
Founder
Barak Ben-Arye
General Counsel
Ashley Cordova
Chief Financial Officer
Wilco Groenhuysen
Chief Operating Officer
Frank Leonard
President, CNS Cancers U.S.
Pritesh Shah
Chief Growth Officer
Uri Weinberg, M.D., Ph.D.
Chief Innovation Officer
Moshe Giladi, Ph.D.
Chief Science Officer
Michael Puri
Chief Human Resources Officer
our board of directors
William F. Doyle
Executive Chairman
Asaf Danziger
Chief Executive Officer
contact Novocure
Thank you for your interest in Novocure. Please click the link below, complete and submit the contact form, or use the company directory to find a specific business unit or location.
contact Novocure